Aminoglycoside antibiotics such as streptomycin and tobramycin must traverse the bacterial cytoplasmic membrane prior to initiating lethal effects. Previous data on Escherichia coli, Staphylococcus aureus, and Bacillus subtilis have demonstrated that transport of aminoglycosides is regulated by At, the electrical component of the proton motive force. However, several laboratories have observed that growth of bacterial cells can occur in the apparent absence of At, and we wished to confirm these studies with E. coli and further investigate whether transport of aminoglycosides could occur in the absence of a membrane potential. Treatment of acrA strain CL2 with the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) dissipated A*, decreased intracellular ATP levels, and resulted in cessation of growth; after a variable period of time (3 to 7 h), growth resumed, ultimately achieving growth rates comparable to those of untreated cells.
Facultative bacteria can actively transport low-molecularweight substrates across the bacterial cytoplasmic membrane. The proximate energy for these transport processes is most often either ATP or the electrochemical proton gradient. The electrochemical proton gradient (proton motive force, Ap,H+) is expressed by the equation AluH+ = AT -Z ApH, where At and ApH are the electrical and chemical components of A4LH+ (Z = 61.5 at 37°C). The active transport of some substrates, such as the amino acids proline and lysine, is under certain circumstances directly proportional to the magnitude Of AHp+ or one of its components (At alone or ApH alone) (1, 5, 20) . The transport of other substrates, such as the amino acids methionine and leucine, requires only ATP and is independent of A'4H+ (22) .
The members of the aminoglycoside class of antibiotics are small cationic molecules that must traverse the bacterial cytoplasmic membrane prior to interacting with the ribosome and initiating lethal events. Data from our laboratory on Staphylococcus aureus have demonstrated that the transport of aminoglycosides, as well as aminoglycoside-induced killing, is regulated by the proton motive force. More spe- 06492. cifically, uptake is dependent on AlT, the electrical component of the proton motive force, and is also gated; i.e., a minimum threshhold of energy is required for the induction of transport (12, 33) . These observations, which have been confirmed by other investigators with a variety of bacterial strains, including Escherichia coli, Bacillus subtilis, and S. aureus, are consistent with Mitchell's chemiosmotic hypothesis (4, 9, 16) . This hypothesis predicts that the transport of cations is driven by Atl alone, which is interior negative (36, 37) . However, there are little data on whether or not AT has a thermodynamic or regulatory role in aminoglycoside transport. In addition, intracellular ATP levels and AH+ are directly coupled and interconvertible via the bidirectional proton-translocating ATPase enzyme complex (H+-ATPase complex) so that perturbations of one energy mode will frequently affect the other. For example, protonophores, chemicals which dissipate APH+, will also decrease ATP levels because of reverse proton flow through the H+-ATPase complex. Although many experimental manipulations used in previous studies of aminoglycoside transport would not be expected to alter intracellular ATP content, ATP levels were not directly measured, and the importance of ATP as an independent factor in the energy-dependent transport of aminoglycosides is unknown.
Several laboratories have observed that growth of bacterial cells can occur in the apparent absence of At (19, 27) . In these studies, chemicals known to dissipate At were added to the media of E. coli or Enterococcus faecalis cells during logarithmic growth; initially there was cessation of growth, (8, 20) .
MATERIALS AND METHODS
Growth and preparation of cells. See Table 1 for characteristics and derivation of strains used in this study. Cells were grown overnight to early logarithmic phase in modified LBM medium (10 g of tryptone, 5 g of yeast extract, 5 g of NaCl, 5 g of glucose per liter of water) or M9 minimal medium containing 0.5% glucose or 0.5% succinate as a carbon source at 37°C in a gyratory shaker bath (New Brunswick Scientific model G76). For most experiments, medium pH was maintained at 7.5 by additional buffers, either 50 mM potassium phosphate (pH 7.5) or 100 mM Tris hydrochloride (pH 7.5).
Viability assays. Growth was monitored by optical density determinations on a Coleman spectrophotometer (model 6-20A) at 600 nm. Growth rates or cell viability or both were also determined with and without antibiotics by standard pour plate techniques, using LBM agar (LBM medium plus 1.5% agar).
Determination of A*. The determination of AT (interior negative) was performed by measuring the distribution of the lipophilic cation [3H]tetraphenylphosphonium (TPP+) as described previously (12) . In these studies we used TPP+ (specific activity, 26 Ci/mmol; 962 GBq/mmol) at a final concentration of 20 (42) . Protein content was measured as described by Lowry et al., with crystalline bovine serum albumin as the standard (32 4.9 Ci/mmol; 181 GBq/mmol), except that glass microfiber filters (Whatman GF/C) were used and 2-ml filtered samples were washed twice with 1 volume of 3% sodium chloride.
For proline and methionine uptake, filtration assays were performed on logarithmic-phase cells which were washed and resuspended in 50 mM potassium phosphate buffer, pH 7.5 (with or without CCCP). Cells were treated with chloramphenicol (100-pug/ml final concentration) 3 (8, 20) . This defect, although incompletely characterized, is presumed to be due to differences in lipopolysaccharide phosphate linkages functionally analogous to treatment of the cells with the chelating agent EDTA (7a, 8, 31 (20) . Figure 1 shows measurement of [3H]TPP+ uptake in the acrA strain CL2 and the isogenic acrA+ strain PL2 at pH 7.5 (where ApH 0 and ARH+ AP). There is rapid uptake of TPP+ in response to membrane potential in strain CL2, and equilibrium is reached by 10 min; no uptake is seen in strain PL2. However, when the outer membrane of the wild-type strain PL2 is rendered permeable to TPP+ by the addition of 5 mM EDTA, uptake of TPP+ is comparable to that seen in strain CL2; addition of EDTA did not further stimulate uptake of TPP+ in strain CL2 (data not shown). Treatment of strain CL2 with the protonophore CCCP resulted in dissipation of At in a dose-dependent manner (Fig. 1, inset) . Concentrations Figure 2A shows a representative experiment with acrA strain CL2 which was exposed to 16 ,uM CCCP. For discussion purposes, we have defined five phases of growth, I through V, in these cells. Phase I is the phase of exponential growth prior to the addition of CCCP; phase II is the brief initial period after CCCP addition, during which there is a transition and decline in the rate of increase in culture turbidity; phase III is the plateau phase; phase IV is the phase of early resumption of growth; and phase V occurs when rates of growth for CCCP-treated cells are equivalent to those of untreated (phase I) cells. Figure 2A (inset) demonstrates the equivalent growth rates of phase I and phase V cells (passaged for >5,000 cell doublings in the presence of 16 ,uM CCCP). These studies were also repeated in strain AS1, another acrA mutant (20) , and similar growth curves were obtained at CCCP concentrations of 30 to 50 ,uM (data not shown).
The observation that growth resumed after a plateau phase in concentrations of CCCP known to dissipate AtI suggested that the energy requirements for all growth-related transport processes did not absolutely include an electrochemical proton gradient. Importantly, Ap.H+ and intracellular ATP are interconvertible through the proton-translocating ATPase complex, and treatment of cells with CCCP might also be expected to indirectly affect (i.e., decrease) intracellular ATP levels. We therefore measured both At (since 4W 5AT at pH 7.5) and ATP levels during the various phases of growth to characterize better the total cellular bioenergetics of our system. Figure 2B shows relative levels of At (as determined by TPP+ uptake) and intracellular ATP (as measured by bioluminescence assay) in strain CL2 during growth phases I, II, and V in enriched medium (LBM plus 0.5% glucose, pH 7.5). Treatment with CCCP (phase II) is associated with dissipation of At as well as a decrease in ATP content to 50% of normal cell base-line values in these experiments. Data were similar for cells grown in minimal medium containing glucose (M9 plus 0.5% glucose, pH 7.5), but when succinate was used as the sole carbon source (M9 plus 0.5% succinate, pH 7.5), ATP levels fell to <10% of normal cell base-line values (data not shown). AT and ATP levels throughout phase III were similar to those measured in phase II (data not shown). During regrowth (phases IV and V), At remains unmeasurable, but intracellular ATP levels have returned to base line, suggesting that phase V growth is associated with restoration of intracellular ATP.
We next undertook a series of experiments to exclude TIME. rigorously the possibility that the apparent absence of At in phase II through V cells was simply due to experimental artifact or inability to measure true values of AT in these cells with the TPP+ probe. First, we directly examined whether or not CCCP-treated cells were motile at pH 7.5 (where AUH+ AT), using phase-contrast microscopy. The flagellar motor is known to be ApH+ dependent and is gated at -30 mV (25) . Swimming motion was observed in phase I but not phase V cells, implying that At in phase V cells was below the levels necessary for flagellar motion (i.e., >-30 mV). In addition, we measured uptake of the amino acid proline in phase I and phase V cells. In E. coli, there are at least two mechanisms of proline uptake, one driven by the sodium electrochemical gradient (Ap\Na+) and the other driven by the proton electrochemical gradient (5, 21). However, in E. coli ApuNa+ is generated by Na+/H+ antiport, and as a result both proline transport systems require ApRH+.
Phase V cells, unlike phase I cells, did not take up proline (Fig. 3A) . However, when phase V cells were then resuspended in CCCP-free potassium phosphate buffer, there was uptake of proline comparable to that demonstrated in phase I cells. For comparison, the uptake of methionine in phase I and V cells is also shown (Fig. 3B) . Methionine is known to be transported via an ATP-dependent, osmotically shockable carrier system (22) . Equivalent uptake of methionine was seen in phase I and V cells. Ability to transport methionine but not proline during phase V supports the conclusion that these cells lack a membrane potential but maintain normal levels of ATP. The reestablishment of proline transport in phase V cells resuspended in CCCP-free buffer suggests that, in the absence of protonophores, phase V cells regenerate Ap.H+ from ATP stores via an intact H+ATPase complex.
To ensure that CCCP was not "lost" from our experimental system by breakdown or adherence to glass, a bioassay for CCCP was performed and confirmed that CCCP was still present in the medium of phase V cells. When phase V cells were separated from their medium by filtration and resuspended in fresh CCCP-containing medium, they continued to grow without an alteration in growth rate, while the filtrate completely inhibited growth when added to fresh phase I cultures. Finally, to ensure that phase V cells do not develop resistance to CCCP or the TPP+ probe by restoration of an outer membrane barrier analogous to that seen in wild-type (acrA+) cells or in recently described "uncoupler resistant" mutants (30, 41) , we performed additional control experiments. In these studies, phase I and V cells were washed and resuspended in either 50 mM potassium phosphate buffer, pH 7.5, or buffer containing 16 mM CCCP, and [3H]TPP+ uptake was then measured (Fig. 3C) . As anticipated from the proline uptake experiments (Fig. 3A) 
TIME -MINI
To characterize further the energy requirements of uptake in normally growing (phase I) cells, we used a strain carrying the AuncBC mutation (7) . This class of mutants is deficient in all proteins in the proton-translocating ATPase complex and is unable to hydrolyze ATP in response to treatment with the protonophore CCCP (3). In these cells, AT can be selectively dissipated without decreasing intracellular ATP levels. Figure 5A demonstrates the comparison of [3H]tobramycin uptake in HF2 (a AuncBC derivative of CL2) before and immediately after the addition of 8 ,uM CCCP (phases I and II). Similar data were also obtained at higher (16 ,uM) concentrations of CCCP (data not shown). Figure 5B shows the relative levels of ATP and At in strain HF2 and its parent strain CL2 during phase I (no CCCP) or II (plus 8 4. [3H]tobramycin uptake in E. coli acrA CL2 during phases I (0), II (O), and V (*) in LBM plus 100 mM Tris hydrochloride, pH 7.5. Tobramycin (16x MIC) was added to all cells at time zero, and [3H]tobramycin uptake assays were performed as described previously (35) in continuously aerated broth cultures at 37°C. CCCP at 16 ,uM was added to phase II cells 5 min prior to the addition of tobramycin. At the intervals shown, 2-ml samples were removed, filtered through prewashed glass microfiber filters, and washed with 2 volumes of 3% sodium chloride.
CCCP-free buffer, but this was significantly less than the uptake exhibited by the phase V cells, perhaps because of the decreased ATP levels of phase II cells relative to phase V cells (Fig. 2B) . In all cases, subsequent addition of CCCP to the buffer immediately reabolished TPP+ uptake. The instantaneous ability to affect TPP+ uptake by addition or removal of CCCP excludes the possibility that phase V growth is due to a phenotypic alteration of outer membrane function.
Having sufficiently characterized and validated the bioenergetic characteristics of our model system, we then examined the relationship between cellular energy and aminoglycoside uptake. Figure 4 demonstrates the comparison of uptake of [3H]tobramycin as determined by membrane filtration in phase I, II, and V CL2 cells. Uptake occurred in both phase I and V cells, but not in phase II cells. Aminoglycoside-induced killing was seen in association with uptake during phases I and V, but was abolished during phase II, confirming that measured counts represent functional aminoglycoside uptake and not merely binding to the bacterial cell envelope. These studies also suggest that energydependent aminoglycoside uptake in phase V is driven by ATP (or another high-energy activated phosphate donor), since At is zero.
The unique role of ATP in phase V aminoglycoside transport was further demonstrated by treatment of phase V cells with increasing concentrations of arsenate. When treated with concentrations of arsenate which decrease intracellular ATP (range, 15 to 100% of controls) without altering At (28), aminoglycoside-induced killing was reduced in a dose-dependent manner and was proportional (r = 0.98) to the levels of intracellular ATP (data not shown). Arsenate treatment had no effect on aminoglycoside-induced killing in phase I cells, suggesting that phase I uptake is ATP independent. CL2, HF2 cells will ultimately regrow in the presence of CCCP (phase V) and will then transport aminoglycosides in an ATP-dependent fashion (data not shown). These data also suggest that regrowth is not associated with an alteration in the H+-ATPase complex described in one class of uncoupler-resistant mutants (30) . DISCUSSION This work enlarges on previous studies from our laboratory and others demonstrating a regulatory role for AP in the transport of aminoglycosides across the bacterial cytoplasmic membrane (4, 9, 12, 16, 33) . Furthermore, we have confirmed previous studies by others suggesting that continued cell growth can occur in the absence of an electrochemical proton gradient (19, 27) . By careful quantification of cellular energy metabolism, including both AP and ATP, we have confirmed that, in normally growing cells, treatment with CCCP (which dissipates AT) blocks aminoglycoside transport, even in the presence of normal cellular ATP levels. However, we have also demonstrated that, after a period of adaptation, cells are able to grow in the presence of CCCP and in the apparent absence of a membrane potential (phase V growth). In a rigorously characterized system, these cells grow at rates equivalent to that of untreated (phase I) cells in glucose-but not succinate-containing medium and maintain normal cellular ATP levels despite the absence of At. In addition, these cells transport aminoglycosides in proportion to their ATP content and not in response to At.
Many previous studies have corroborated our data suggesting a role for AT as one of several independent factors which regulate the energy-dependent transport of aminoglycosides in normally growing bacterial cells (4, 9, 12, 33) . hn most of these studies the role of ATP was not specifically addressed, but more recent data from Goss et al., as well as the data here, confirm that transport is generally not influenced by the levels of intracellular ATP (17) . Although the bioenergetics of aminoglycoside transport have been fairly well characterized, neither the function of energy (thermodynamic, regulatory) nor the mechanism by which aminoglycosides penetrate the cytoplasmic membrane has been elucidated (10, 43 (23, 24) , anaerobic growth (23, 24, 34) , or low pH (3, 33, 34, 40) . We believe that the ability to switch energy modes may represent a general adaptive response to such hostile environments.
One potential explanation for the phenomenology of phase V growth would be development of resistance to the uncoupling agent CCCP. Uncoupler-resistant mutants have been described in both E. coli and Bacillus species (11, 18, 30, 41) . At least some of the E. coli mutants described are thought to result in exclusion of uncoupling agents from the energized cytoplasmic membrane via alterations in outer membrane barrier function (30, 41) ; in Bacillus spp., there are also mutations that remain sensitive to uncoupling agents but whose membranes are somehow altered to function at reduced (but still measurable) levels of membrane potential (11, 18) . The relatively short (i.e., 3-to 7-h) period required for resumption of growth in CL2 cells treated with CCCP suggests that mutation is not the mechanism of phase V growth. Phenotypically, phase V cells show no evidence of enhanced outer membrane barrier function when compared with untreated CL2 cells (Fig. 3B) ; also, the ability to transport proline should be maintained because of the persistence of an intact membrane potential. In addition, measurable AILH+ in our cells was much less (no flagellar motion, no measurable TPP+ or proline uptake) than even the minimum levels required by the membrane-altered Bacillus mutants that have been reported (30) . Even were the membrane potential in phase V cells to derive from an electrochemical gradient other than a gradient of protons (for example, Na+), the effective gradient should still be measurable by either the TPP+ probe or ability to transport proline (2, 5) . Thus, it is quite unlikely that any type of electrical or chemical membrane potential can account for the transport of aminoglycosides in phase V cells.
While the mechanism of aminoglycoside transport in phase V cells has not been thoroughly investigated, it is clearly associated with the restoration of intracellular ATP levels. When AuncBC mutants are treated with CCCP, ATP levels do not fall. Nevertheless, they undergo an identical phase of growth cessation prior to entering phases IV and V. The nature of the adaptive response associated with a fall in AjiU+ has not been explored. However, preliminary experiments in which phase III cells were pulsed with chloram- CCCP-containing medium show that the delay in onset of growth seen in phases IV and V is proportional to the duration of the chloramphenicol pulse. This suggests that induction of protein synthesis is required for adaptation and regrowth in the absence of AIH+. Since many events required for rapid growth were thought to be ApH+ dependent, it is highly unlikely that the induction process represents a novel aminoglycoside transport system. More likely, the proteins involved in both phase V growth and phase V aminoglycoside transport would be part of a global energy regulatory process that is induced by a fall in membrane potential. This could be a new, as yet uncharacterized global response system or a component of one of the other previously described stress response systems known to be operative in bacterial cells (15) .
